Consensus SMAIO

Stocks

ALSMA

FR0014005I80

Pharmaceuticals

Market Closed - Euronext Paris 19:55:00 02/10/2026 +04			5-day change	1st Jan Change
6.660 ^EUR	-1.48%		-6.46%	+6.56%

07-16	SMAIO Reports Group Sales Results for the Second Quarter and First Half Ended June 30, 2026	CI
07-16	SMAIO Continued Expansion of the Network in the United States, with 5 New Centers Added to the Network and 13 New Surgeons Who Have Performed Their First Implants	CI

Evolution of the Average Target: SMAIO

Evolution of the Target Price: SMAIO

Changes in Analyst Recommendations: SMAIO

48ce9ca36e3a6229c4adb186c35afd2.HsNQ1rrbh9wTdgGE0gMm5S9QsMLVjhTNiWAEJPw_hq8.TaE2homOwporETi0kFATh1wagvvs0VGg4iVOQb180_tOqDSe3aPv70NDSA~27192184453c2306594698ea2aa018c8

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	SMAIO			-	-	+21.3%
	ELI LILLY AND COMPANY					+15.57%
	JOHNSON & JOHNSON					+7.97%
	ABBVIE INC.					+7.28%
	MERCK & CO., INC.					+8.31%
	ROCHE HOLDING AG					+7.55%
	NOVARTIS AG					+6.77%
	ASTRAZENECA PLC					+32.41%
	AMGEN INC.					-4.01%
	GILEAD SCIENCES, INC.					+7.56%
	Average					+11.07%
	Weighted average by Cap.					+10.77%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

OUTPERFORM

Number of Analysts

2

Last Close Price

6.660EUR

Average target price

8.200EUR

Spread / Average Target

+23.12%

High Price Target

8.200EUR

Spread / Highest target

+23.12%

Low Price Target

8.200EUR

Spread / Lowest Target

+23.12%

Analyst Consensus Detail

Consensus revision (last 18 months)

As early as today, start finding the best investment opportunities!